MedPath

ANIDULAFUNGINA FRESENIUS KABI 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIÓN EFG

ANIDULAFUNGINA FRESENIUS KABI 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIÓN EFG

Pending
Register Number

84619

Prescription Type

Uso Hospitalario

Authorization Date

Nov 6, 2019

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number84619
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

ANIDULAFUNGINAActive
Quantity: 100 mg
Name: ANIDULAFUNGINA

ATC CLASSIFICATION (3)

J02A
J02AX
J02AX06

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.